Helicobacter pylori treatment: A role for probiotics?

Filippo Cremonini, Filippo Canducci, Simona Di Caro, Luca Santarelli, Alessandro Armuzzi, Giovanni Gasbarrini, Antonio Gasbarrini

Research output: Contribution to journalArticle


Many new therapeutic strategies are studied to improve Helicobacter pylori eradication rate. Probiotics are live microorganisms which, upon administration, may interact with the human microflora and positively affect the health status. The use of probiotics in the field of H. pylori infection has been proposed for improving eradication rate and tolerability and for compliance of multiple antibiotic regimens used for the infection. Results from laboratory studies and from clinical trials seem to confirm the expectancies, but there is lack of standardization in terms of type of probiotic strain used, dosage and timing of supplementation. Before further ongoing trials and future studies will clarify these points, probiotics could remain a useful adjunct to standard anti-H. pylori therapies, but cannot take the place of other validated options.

Original languageEnglish
Pages (from-to)144-147
Number of pages4
JournalDigestive Diseases
Issue number2
Publication statusPublished - 2001


  • Helicobacter pylori
  • Lactobacillus
  • Probiotics

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Helicobacter pylori treatment: A role for probiotics?'. Together they form a unique fingerprint.

  • Cite this

    Cremonini, F., Canducci, F., Di Caro, S., Santarelli, L., Armuzzi, A., Gasbarrini, G., & Gasbarrini, A. (2001). Helicobacter pylori treatment: A role for probiotics? Digestive Diseases, 19(2), 144-147. https://doi.org/10.1159/000050669